TRANS11 Antibody

What is the trans-11 configuration and why is it significant in fatty acid research?

The trans-11 configuration refers to a specific molecular structure in fatty acids where there is a trans double bond at the 11th carbon position. This configuration is particularly significant in conjugated linoleic acid (CLA), especially the cis-9, trans-11 CLA isomer which is naturally found in dairy products and ruminant meat. The trans-11 configuration creates unique biological properties that have been associated with various health benefits, making it an important target for antibody-based detection and research .

What are the primary biological sources of cis-9, trans-11 CLA?

The primary biological sources of cis-9, trans-11 CLA are ruminant-derived foods, particularly dairy products and beef. This fatty acid is produced through biohydrogenation of dietary polyunsaturated fatty acids by rumen bacteria. According to research data, the plasma concentration of trans11-18:1 and cis9, trans11-CLA can serve as biomarkers of dairy product consumption, with significant correlations observed in both intervention and observational studies . Studies show that plasma levels of these fatty acids correlate strongly with dairy intake, with determination coefficients (R²) of 0.771 for trans11-18:1 and 0.804 for cis9, trans11-CLA in intervention studies .

How does cis-9, trans-11 CLA affect cellular mechanisms?

Cis-9, trans-11 CLA influences multiple cellular mechanisms, particularly in cancer cell lines. Research indicates that it can inhibit cell proliferation by affecting cell cycle progression. Studies on mammary cancer cells (MCF-7) demonstrated that cis-9, trans-11 CLA significantly decreased the expressions of PCNA (proliferating cell nuclear antigen) and cyclins A, B1, and D1 compared to control conditions . Treatment with various concentrations (25 μM, 50 μM, 100 μM, and 200 μM) for 8 days resulted in inhibition frequencies of 27.18%, 35.43%, 91.05%, and 92.86%, respectively, demonstrating a dose-dependent effect .

What techniques are used to detect and quantify trans-11 fatty acids in biological samples?

Multiple analytical approaches are employed for the detection and quantification of trans-11 fatty acids in biological samples:

• Chromatographic methods: Gas chromatography (GC) and high-performance liquid chromatography (HPLC) coupled with mass spectrometry are commonly used for precise identification and quantification.

• Immunological assays: Antibodies specific to the trans-11 configuration can be employed in ELISA, immunohistochemistry, or Western blotting applications.

• Spectroscopic methods: Infrared spectroscopy can identify specific bond configurations characteristic of trans fatty acids.

Research on plasma fatty acids demonstrates that analytical methods can detect even small concentrations of trans11-18:1 and cis9, trans11-CLA with sufficient sensitivity to serve as biomarkers for dairy consumption .

How can researchers optimize experimental designs when studying cis-9, trans-11 CLA effects?

Based on published research protocols, optimal experimental designs for studying cis-9, trans-11 CLA effects should include:

• Dose-response relationships: Testing multiple concentrations (25-200 μM) to establish threshold effects and maximum responses .

• Time-course experiments: Examining both short-term (24 h) and longer-term (48 h and beyond) exposures to capture immediate and delayed effects .

• Appropriate controls: Including vehicle controls (typically 0.1% ethanol) and positive controls where applicable .

• Multiple endpoint measurements: Assessing various cellular parameters including proliferation, DNA synthesis, protein expression, and functional outcomes .

• Verification with multiple techniques: Confirming key findings using complementary methodological approaches such as qPCR, immunocytochemistry, and biochemical assays .

What mechanisms underlie cis-9, trans-11 CLA's effects on cancer cell cycles?

Research indicates that cis-9, trans-11 CLA affects cancer cell cycles through multiple mechanisms:

• Inhibition of DNA synthesis: MCF-7 cells treated with cis-9, trans-11 CLA incorporated significantly less 3H-TdR than control cells, indicating reduced DNA synthesis .

• Cell cycle arrest: Cis-9, trans-11 CLA can arrest the cell cycle progression in cancer cells .

• Modulation of cell cycle regulatory proteins: Immunocytochemical staining demonstrated that MCF-7 cells treated with different cis-9, trans-11 CLA concentrations showed significantly decreased expressions of PCNA and cyclins A, B1, and D1 compared with negative controls (p<0.01), while increasing the expressions of p16ink4a and p21cip/waf1, which are cyclin-dependent kinase inhibitors .

• Dose-dependent growth inhibition: The inhibitory effect increases with concentration, with particularly pronounced effects at 100 μM and 200 μM .

These findings suggest that cis-9, trans-11 CLA could be a potential candidate for cancer prevention and therapy through its effects on cell cycle regulation.

How does the inhibitory effect of cis-9, trans-11 CLA vary across different cancer cell types?

The inhibitory effect of cis-9, trans-11 CLA shows variation across different cancer cell types, suggesting tissue-specific responses:

• MCF-7 cells (breast cancer): Research demonstrates significant inhibition of cell proliferation, with inhibition frequencies of up to 92.86% at 200 μM concentration .

• SGC-7901 cells (gastric cancer): Studies indicate that c9, t11-CLA could inhibit cell proliferation of these gastric cancer cells .

This differential response may be related to variable expression of receptors and regulatory proteins involved in cell cycle control across cancer cell types, highlighting the importance of studying multiple cell lines when investigating the anti-cancer potential of trans-11 fatty acids.

How does cis-9, trans-11 CLA affect oxidative stress pathways?

Cis-9, trans-11 CLA appears to alleviate oxidative stress in cellular models through multiple mechanisms:

• Modulation of Nrf2 pathway: This key transcription factor regulates antioxidant responses, and cis-9, trans-11 CLA affects its expression in lipopolysaccharide (LPS)-challenged cells .

• Regulation of antioxidant enzymes: Treatment with cis-9, trans-11 CLA affects the mRNA expression of key antioxidant enzymes including NQO1, HMOX1, SOD1, and CAT .

• Improvement of redox status: CLA treatment influences the activity of antioxidant enzymes like CAT and SOD, as well as the concentration of GSH and TBARS .

• Protection against induced oxidative stress: Studies show that cis-9, trans-11 CLA at concentrations of 50 μM and 100 μM can ameliorate LPS-induced oxidative stress in bovine mammary epithelial cells .

What methodological approaches are recommended for studying CLA's effects on oxidative stress?

When investigating CLA's effects on oxidative stress, researchers should consider:

• Multiple experimental groups: Designs should include untreated controls, CLA treatment alone, oxidative stress inducer alone (such as LPS), and combined treatment groups .

• Concentration-dependent effects: Testing multiple concentrations (50 μM and 100 μM are commonly used) to determine dose-response relationships .

• Comprehensive biomarker assessment: Measuring multiple markers of oxidative stress including enzyme activities (CAT, SOD) and metabolite concentrations (GSH, TBARS) .

• Gene expression analysis: Utilizing qPCR to assess the expression of genes involved in antioxidant responses and fatty acid synthesis .

• Protein expression verification: Confirming gene expression changes at the protein level through Western blotting .

How can trans-11 fatty acids serve as biomarkers for dietary intake?

Trans-11 fatty acids, particularly trans11-18:1 and cis9, trans11-CLA, can function as reliable biomarkers for dairy product consumption:

• Strong correlation with intake: In intervention studies, plasma concentrations of these fatty acids show high determination coefficients with dairy fat intake (R² = 0.771 for trans11-18:1 and R² = 0.804 for cis9, trans11-CLA) .

• Improved prediction with combined markers: The sum of plasma concentrations of selected fatty acids (trans11-18:1, cis9, trans11-CLA, iso16:0, iso17:0, and cis6-18:1) provides an even stronger correlation (R² = 0.871) .

• Detection in different biological matrices: These fatty acids can be measured in both plasma and erythrocytes, though with different correlation strengths .

***, p < 0.001; **, 0.001 < p < 0.01

What are the methodological considerations for antibody development targeting trans-11 configurations?

Developing antibodies specific to the trans-11 configuration presents several methodological challenges:

• Epitope design: The trans-11 configuration represents a subtle structural feature that requires careful consideration in hapten design.

• Carrier protein selection: Lipid antigens typically require conjugation to carrier proteins to elicit robust immune responses.

• Specificity testing: Extensive cross-reactivity testing against structurally similar fatty acids (cis-11, trans-10, etc.) is essential.

• Validation across applications: Antibody performance should be validated in multiple assay formats including ELISA, immunohistochemistry, and Western blotting.

• Correlation with standard methods: Results from antibody-based detection should be compared with established chromatographic methods to ensure accuracy.

What are the primary challenges in studying trans-11 fatty acids in complex biological systems?

Researchers face several challenges when investigating trans-11 fatty acids:

• Isomerization risk: Trans fatty acids can undergo isomerization during extraction and analysis, potentially confounding results.

• Low natural abundance: The relatively low concentrations of specific trans-11 fatty acids in biological samples necessitate sensitive detection methods.

• Physiological relevance: Determining appropriate concentrations for in vitro studies that reflect physiological levels observed in vivo can be challenging.

• Background matrix effects: Complex biological matrices may contain interfering compounds that affect detection specificity.

• Standardization across studies: Lack of standardized methodologies makes cross-study comparisons difficult.

What emerging technologies might enhance trans-11 fatty acid research?

Several emerging technologies hold promise for advancing trans-11 fatty acid research:

• Advanced mass spectrometry: High-resolution and ion mobility MS techniques enable more specific identification of fatty acid isomers.

• Novel immunoassay formats: Improved antibody engineering and detection platforms may enhance specificity for trans-11 configurations.

• Microfluidic systems: These allow for reduced sample volumes and potentially higher throughput analysis.

• Computational modeling: Molecular dynamics simulations can help predict interactions between trans-11 fatty acids and their biological targets.

• Systems biology approaches: Integration of multi-omics data can provide comprehensive understanding of trans-11 fatty acid effects across biological networks.